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Membrane active antimicrobials 
A B S T R A C T   
Successful treatment of skin infections requires eradication of biofilms found in up to 90 % of all chronic wounds, 
causing delayed healing and increased morbidity. We hypothesized that chitosan hydrogel boosts the activity of 
liposomally-associated membrane active antimicrobials (MAA) and could potentially improve bacterial and 
biofilm eradication. Therefore, liposomes (~300 nm) bearing chlorhexidine (CHX; ~50 μg/mg lipid) as a model 
MAA were incorporated into chitosan hydrogel. The novel CHX-liposomes-in-hydrogel formulation was opti-
mized for skin therapy. It significantly inhibited the production of nitric oxide (NO) in lipopolysaccharide (LPS)- 
induced macrophage and almost completely reduced biofilm formation. Moreover, it reduced Staphylococcus 
aureus and Pseudomonas aeruginosa adherent bacterial cells in biofilm by 64.2–98.1 %. Chitosan hydrogel boosted 
the anti-inflammatory and antimicrobial properties of CHX.   
1. Introduction 
Antimicrobial resistance is currently a serious medical threat, espe-
cially because of the decelerated and unsuccessful pipeline of antimi-
crobial candidates (Hall et al., 2020). Although bacterial resistance often 
derives from genetic mutations, the biofilm formation and increased 
inflammatory cascades are also known to be strong contributors 
(Balaure & Grumezescu, 2020; Cepas et al., 2018; Romana-Souza, San-
tos, Bandeira, & Monte-Alto-Costa, 2016). Biofilms are found in between 
60 and 90 % of all chronic wounds, delaying healing and leading to 
increased morbidity and costs (Kadam, Shai, Shahane, & Kaushik, 2019; 
Matos de Opitz & Sass, 2020). Novel approaches for biofilm eradication 
and efficient wound therapy are urgently needed as skin and soft tissue 
infections are among the most common infections in humans (Poulakou, 
Lagou, & Tsiodras, 2019). These infections exhibit a polymicrobial 
nature and cleaver, novel strategies to eradicate multiple bacteria are 
necessary for their treatment. 
Among the most common bacteria embedded in wound matrices are 
Staphylococcus aureus and Pseudomonas aeruginosa (Balaure & Grume-
zescu, 2020; Kadam et al., 2019). These bacteria display multiple 
mechanisms of resistance, rendering their eradication particularly 
challenging. Treating wound biofilms requires innovative approaches. 
Novel drug delivery systems comprising cationic polymers (Guo et al., 
2018) offer potential solutions. Chitosan has attracted a lot of interest 
due to its broad range of beneficial effects and biodegradability 
(Ambrogi et al., 2017; Islam, Shahruzzaman, Biswas, Nurus Sakib, & 
Rashid, 2020). The intrinsic antimicrobial and anti-inflammatory 
properties are highly relevant for wound therapy (Islam et al., 2020). 
Several antimicrobial mechanisms are proposed for chitosan; its inter-
action with negatively charged bacterial membranes leading to possible 
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lysis being the main mechanism (Matica, Aachmann, Tøndervik, Sletta, 
& Ostafe, 2019). Other mechanisms include interruption of microbial 
protein synthesis, chelation of metal ions and formation of an envelope 
on the microbial surface (Matica et al., 2019). In addition, chitosan can 
influence the haemostasis, inflammatory stage and proliferation as well 
as accelerate wound healing (Liu et al., 2018; Moeini, Pedram, Mak-
vandi, Malinconico, & Gomez d’Ayala, 2020). Chitosan hydrogel′s 
three-dimensional network contributes to high water-retaining proper-
ties and gas-exchange capacity (Tavakoli & Klar, 2020). However, 
hydrogels often exhibit rapid drug release from the gel matrix (Peers, 
Alcouffe, Montembault, & Ladavière, 2020). 
Combining hydrogel with a lipid-based carrier, such as liposomes, 
could prevent this rapid drug release (Grijalvo, Eritja, & Díaz, 2020; 
Peers et al., 2020). Studies report considerably slower release from 
liposomes-in-hydrogels compared to plain hydrogels (Jøraholmen, 
Basnet, Tostrup, Moueffaq, & Škalko-Basnet, 2019). The release will be 
also influenced by the type of entrapped drug. Antiseptics, such as 
chlorhexidine (CHX), are commonly used in local treatment of wound 
infection and reasonable candidates for new topical formulations 
(Smith, Russo, Fiegel, & Brogden, 2020). CHX acts as a membrane active 
antimicrobial (MAA) on both the dormant and active bacteria (Hubbard, 
Coates, & Harvey, 2017). The resistance is generally lower than for more 
target-specific compound due to the rapid and broad bactericidal effect 
of MAAs (Hubbard et al., 2017). Their mechanism of action could, in 
synergy with chitosan, enhance eradication of resistant bacteria. 
Several researchers reported promising results on the antimicrobial 
effects of chitosan hydrogel and hydrogels containing carriers or parti-
cles. Anjum et al. evaluated a cotton dressing coated with chitosan, 
polyethylene glycol and polyvinyl pyrrolidone gel loaded with tetracy-
cline against Escherichia coli and S. aureus (Anjum, Arora, Alam, & 
Gupta, 2016). In another study, the authors showed effect in the same 
species of both chitosan and a multi-network hydrogel based on chitosan 
(Zou et al., 2018). Masood and collaborators reviled antimicrobial ac-
tivity in several species of silver nanoparticles loaded in chitosan and 
polyethylene glycol hydrogels (Masood et al., 2019). In addition, mox-
ifloxacin entrapped in niosomes loaded into chitosan hydrogel demon-
strated an improved antimicrobial activity in P. aeruginosa (Sohrabi, 
Haeri, Mahboubi, Mortazavi, & Dadashzadeh, 2016). The antimicrobial 
effects of chitosan are often greater in gram-positive bacteria (Moeini 
et al., 2020). However, a study on S. aureus and P. aeruginosa co-existing 
in biofilm exposed increased vulnerability of P. aeruginosa. The finding 
that bacterial membrane exhibited higher fluidity in the presence of 
MAAs could lead to novel target in biofilm treatment of wounds (Orazi, 
Ruoff, & O’Toole, 2019). Since these bacteria are often highly abundant 
in wounds, we aimed to exploit this vulnerability and create a system 
with synergic effects on the bacterial membrane. The activity of chitosan 
on the bacterial membrane is often associated with the molecular weight 
(MW) of the polymer (Tao, Qian, & Xie, 2011), and to achieve the 
strongest membrane activity on these bacteria in biofilms, we utilized 
chitosan with higher MW. The action of chitosan combined with the 
membrane activity of CHX could promote eradication of S. aureus and 
P. aeruginosa biofilms. 
We therefore hypothesized that chitosan hydrogel can boost the ac-
tivity of liposomally-associated MAAs. We aimed, for the first time, to 
investigate potential synergy between CHX, a model MAA, associated 
with liposomes and chitosan hydrogel against S. aureus and P. aeruginosa 
biofilms. 
2. Materials and methods 
2.1. Materials 
Chitopharm™ M - Medium MW chitosan from shrimp (average of 
350–600 kDa; and degree of deacetylation of >70 %) was a gift from 
Chitinor (Tromsø, Norway) and Lipoid S100 (phosphatidylcholine con-
tent >94 %) a gift from Lipoid GmbH (Ludwigshafen, Germany). 
Methanol (≥99.9 %) was purchased from VWR (Fontenay-sous-Bois, 
France). Acetic acid ≥99.8 %, chlorhexidine >99.5 %, glycerol solution 
(86–89 %), sodium nitrite, Kollisolv® PEG E 400, Cell Counting Kit – 8, 
Trizma base, calcium chloride, sodium phosphate dibasic dehydrate, 
potassium dihydrogen phosphate, sodium chloride and crystal violet 
were acquired from Sigma-Aldrich (St. Louis, USA). Ortho-phosphoric 
acid ≥85 % was obtained from Kebo Lab Ab (Oslo, Norway). Urany-
less was procured from Electron Microscopy Sciences (Hatfield, PA, 
USA). Lipopolysaccharide (from Escherichia coli 055:B5), sulfanilamide 
≥98 % and N-(1-Naphthyl)ethylenediamine dihydrochloride ≥98 % 
were acquired from Sigma Life Science Norway AS (Oslo, Norway). 
Roswell Park Memorial Institute (RPMI) medium 1640, bovine serum 
albumin, penicillin-streptomycin and fetal bovine serum (FBS) were 
purchased from Sigma-Aldrich (Steinheim, Germany). Nutrient Broth 
(NB) and Brain Heart Infusion broth (BHI) were supplied by Becton 
Dickinson and Company (Sparks, MD, USA). Dulbecco’s Modified Eagle 
Medium (DMEM) high glucose w/ L-glutamine and sodium pyruvate was 
acquired from Biowest (Nuaillé, France). Murine macrophage RAW 
264.7 cells, S. aureus ATCC29213 and P. aeruginosa ATCC10145 were 
delivered by ATCC (Manassas, VA, USA). S. aureus SO88 is a clinical 
isolate (Ospedale Sant’Orsola-Malpighi, Bologna, Italy) (Giordani et al., 
2019). HaCaT cell line (immortalized human keratinocytes) was pur-
chased from CLS Cell Lines Service GmbH (Eppelheim, Germany). 
2.2. Preparation of CHX-liposomes and liposomes 
CHX-liposomes were prepared by the film method as previously 
described (Hurler & Škalko-Basnet, 2012). Briefly, Lipoid S100 
(200 mg) and CHX (10 mg) were dissolved in methanol. A lipid film was 
formed after methanol evaporation on a rotavapor (Büchi rotavapor 
R-124 with vacuum controller B-721, Büchi Vac® V-500, Büchi Labor-
technik, Switzerland) at 60 kPa and 45 ◦C for at least 1 h, and 
re-suspended in 10 mL distilled water to form CHX-liposomes. Lipo-
somes (without CHX) were made of lipid alone. 
The size of CHX-liposomes was reduced by manual extrusion through 
polycarbonate membranes (Nuclepore Track-Etch Membrane, Whatman 
House, Maidstone, UK) with average diameter of 0.8 μm and 0.4 μm 
three and five times, respectively. Liposomes were extruded under same 
conditions including additional extrusions twice through a 0.2 μm 
membrane to be of comparable size. 
2.3. Characterization of CHX-liposomes and liposomes 
The size was measured on a NICOMP Submicron particle sizer 
(NICOMP Particle Sizing System, Santa Barbara, California, USA) as 
described by Ternullo, Gagnat et al. (2019). Liposomal suspensions 
diluted to an attain intensity of 250–350 KHz were measured 
(weight-intensity distribution) in three cycles of 10 min. The zeta po-
tential was determined with a Zetasizer Nano Zen 2600 (Malvern, 
Worcestershire, UK, Jøraholmen et al., 2019). The liposomal suspension 
was diluted with deionized water. The pH of liposomal suspensions was 
measured using sensION + PH31 pH benchtop meter (Hach, Loveland, 
Colorado, USA). 
CHX entrapped in the liposomes was separated from the unentrapped 
CHX using dialysis at 24 ± 1 ◦C (tube cut-off for MW at 12–14 kDa; 
Medicell International Ltd., London, UK). The CHX entrapment effi-
ciency was determined using Tecan Spark M10 multimode plate reader 
(Tecan Trading AG, Switzerland) at 261 nm. A standard curve of CHX 
was prepared in the concentration range of 1.25–40 μg mL− 1 for the 
analysis (R2 = 0.999). 
2.4. Preparation of hydrogels 
2.4.1. Preparation of hydrogel and liposomes-in-hydrogel 
Chitosan hydrogel was prepared as described previously (Hurler, 
Engesland, Kermany, & Škalko-Basnet, 2012). In brief, 4.5 % chitosan 
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(w/w) was dispersed in 2.5 % acetic acid (w/w) and 9% glycerol (w/w) 
and hand-stirred stirring at 24 ± 1 ◦C for 5 min to form hydrogel. The 
hydrogel was bath sonicated in an ultrasonic bath (Branson, Ultrasonic 
cleaner 5510E-MT, Danbury, USA) for 30 min (degassed) and permitted 
to swell at room temperature for 48 h. Glycerol-free hydrogel was pre-
pared in the same manner without glycerol. 
CHX-liposomes or liposomes without drug (10 % w/w) were incor-
porated into hydrogel comprising 5% (w/w) chitosan and 10 % (w/w) 
glycerol by hand-stirring at 24 ± 1 ◦C for 5 min to prepare respective 
liposomes-in-hydrogel. The concentrations of chitosan and glycerol in 
hydrogels after incorporation of liposomes were 4.5 % and 9% (w/w), 
respectively. 
2.4.2. Preparation of CHX-hydrogel 
CHX was dissolved in 2.5 % acetic acid (w/w) and glycerol by me-
chanical stirring for 2 h. Chitosan (4.5 %, w/w) was dispersed in the 
CHX solution and hand-stirred stirring at 24 ± 1 ◦C for 10 min to form 
hydrogel. The final concentrations of chitosan and glycerol were 4.5 % 
(w/w) and 9% (w/w), respectively. 
2.5. Characterization of hydrogel 
Texture properties were evaluated by utilizing a backward extrusion 
rig set using a Texture Analyser TA.XT Plus (Stable Micro Systems Ltd., 
Surrey, UK; Hurler et al., 2012a). Hydrogel (65 g) was transferred to the 
rig set container. A 35 mm disk was fixed to the texture analyser, and 
compressed into the hydrogel, and redrawn to starting position. The 
speed was 4 mm s− 1 and starting position right above the hydrogel 
surface. The distance and trigger force were 10 mm and 10 g, 
respectively. 
The pH of hydrogels was evaluated using Accumet ® portable pH 
meter kit AP115 (Fischer Scientific, Massachusetts, USA). 
2.6. Release of CHX 
The CHX release from formulations (liposomes and hydrogels) and 
free CHX were evaluated in a Franz cell diffusion system (PermeGear, 
Hellertown, PA) utilizing cellophane membrane and acceptor cell of 
12 mL (1.77 cm2) as previously described (Jøraholmen et al., 2019). To 
address low water solubility of CHX base, 10 % polyethylene glycol 
(v/v) in distilled water was added to the acceptor chamber. The system 
was kept on constant heating (32 ◦C) and mechanical stirring. The 
formulation (600 μL) was added to the donor chamber and samples were 
withdrawn after 24 h. CHX from both the acceptor chamber and mem-
brane was quantified on a UV–vis plate reader (SpectraMax 190 
Microplate Reader, Molecular Devices, CA, USA) at 261 nm. The 
hydrogels were weighted before and after each experiment to adjust for 
fluid exchange. 
2.7. Bioadhesion studies 
The bioadhesive properties of hydrogel formulations were evaluated 
using the mucoadhesion rig on the Texture Analyser TA.XT Plus (Stable 
Micro Systems Ltd., Surrey, UK; Hurler & Škalko-Basnet, 2012). The full 
thickness human skin was obtained from patients undergoing abdominal 
plastic surgery. Consent from all patients was obtained prior to every 
surgical procedure. Skin slices (1.26 ± 0.04 mm) were rinsed in Phos-
phate Buffer Saline (PBS, pH 7.4, 2.98 g L− 1 Na2HPO4⋅2H2O, 0.19 g L− 1 
KH2PO4, 8 g L− 1 NaCl) and stored in − 20 ◦C. Prior to each experiment, 
the skin slice was thawed in distilled water for 30 min and rinsed 
thoroughly. Excess liquid was removed and the skin slice was mounted 
to the mucoadhesion rig. The hydrogel (150 μL) was applied to the die 
and the die weighed. The die with hydrogel was pressed onto the skin 
slice for 10 s with a force of 25 g. The speed was set to 1.0, 0.5 and 
0.1 mm s− 1 for the pre-test, test and post-test, respectively. The die was 
immediately weighed after the test (Ternullo, Schulte Werning, 
Holsæter, & Škalko-Basnet, 2019). 
2.8. Anti-inflammatory activity 
The anti-inflammatory activity was expressed through inhibition of 
NO production in lipopolysaccharide-induced RAW 264.7 murine 
macrophages (Basnet, Hussain, Tho, & Škalko-Basnet, 2012). 
CHX-liposomes-in-hydrogel, hydrogel, CHX-liposomes and liposomes 
were evaluated. Cell suspension (5 × 105 cells mL− 1, 1000 μL, in RPMI 
supplemented with glutamine, 10 % FBS, penicillin and streptomycin) 
was added to 24-well plates and incubated in humidified 5% CO2 at 
37 ◦C for 24 h. The medium was removed and 990 μL of LPS (1 μg mL− 1) 
in supplemented RPMI added to each well. The 10 μL of diluted lipo-
somal suspensions (concentrations corresponding to 1, 10 and 50 μg 
mL− 1 lipid content, respectively) and hydrogels (corresponding to 
liposomal suspensions) were added in triplicates. Supplemented RPMI 
(100 %) and LPS in medium served as normal and controls, respectively. 
The cells were incubated in humidified 5% CO2 at 37 ◦C for 24 h. After 
incubation, NO released in medium was measured as nitrite concen-
tration using Griess reagent (1:1, v/v) and quantified on a UV–vis plate 
reader (Tecan Spark M10 multimode plate reader, Tecan Trading AG, 
Switzerland) at 540 nm. 
2.9. Antimicrobial evaluation 
2.9.1. Inhibitory activity against planktonic cultures 
The free and formulated CHX (liposomes and hydrogels, 2.5 mL) 
were diluted in water, mixed with an equal volume of Simulated Wound 
Fluid (SWF, pH 7.4, bovine serum albumin 2% w/v; CaCl2 0.02 M; NaCl 
0.4 M; Trizma base 0.05 M, Cerchiara et al., 2020, final CHX concen-
tration of 0.005 mg mL− 1) and inoculated with microbial suspensions 
(S. aureus ATCC239213, S. aureus SO88 and P. aeruginosa ATCC10145) 
prepared from a broth culture in log phase of growth (inoculum con-
centration: 106 CFU mL− 1). Non-treated suspensions served as a control. 
Counts of viable cells were carried out on NB (S. aureus strains – 
gram-positive) or BHI (P. aeruginosa – gram-negative) plates at the 
inoculum time and after 3, 6, 8 and 24 h of incubation at 37 ◦C. Results 
are expressed as viability (log CFU mL− 1) of microorganisms over time 
in presence of different formulations. 
2.9.2. Anti-biofilm activity 
The anti-biofilm activity of formulations was assessed against 
S. aureus ATCC239213, S. aureus SO88 and P. aeruginosa ATCC10145 as 
described by Giordani et al. (2019). Briefly, two different mechanisms of 
action were targeted, the inhibition of biofilm formation and eradication 
of pre-formed biofilm. For the inhibition assay, 100 μL of bacterial 
suspension (106 CFU mL− 1) in NB (S. aureus strains) or BHI 
(P. aeruginosa) were incubated in 96-multi-well plates together with 
100 μL of free or formulated CHX (liposomes and hydrogels). For the 
eradication assay, the biofilm was first formed for 48 h (200 μL of bac-
terial suspension 106 CFU mL− 1) and then treated with 200 μL of free or 
formulated CHX (liposomes and hydrogels) for 24 h. Crystal violet is a 
dye commonly employed in microbiology field because it allows stain-
ing of the bacterial cell walls. To quantify the biofilm after treatments, 
the cells adherent to the wells were stained with crystal violet (0.41 %, 
w/v), dye exhibiting an absorbance peak at 595 nm when dissolved in 
ethanol. Thus, the higher absorbance (OD595, EnSpire 217 Multimode 
Plate Reader, PerkinElmer Inc., Waltham, MA) corresponds to a larger 
number of bacterial cells adherent to the wells of 96-multi-well plates 
(37 ◦C, 100 rpm). Results were expressed in percentage relative to the 
untreated control accordingly to the following equation (Eq. (1), Gior-
dani et al., 2019):  
Inhibition of biofilm formation/Eradication of pre-formed biofilm (%) = [1- 
(mean OD595 sample / mean OD595 control)] × 100                              (1) 
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2.10. Statistical analyses 
Statistical significance was evaluated by one-way ANOVA followed 
by Turkey’s correction or student’s t-test. The results are expressed as 
means ± SD. 
3. Results and discussions 
The treatment of infected wounds requires careful tailoring of 
formulation properties to optimize the treatment outcome (Malae-
keh-Nikouei, Fazly Bazzaz, Mirhadi, Tajani, & Khameneh, 2020; Tottoli 
et al., 2020). Moreover, the formulation should offer mechanical sta-
bility, moisture maintenance, protection from environmental exposure, 
promotion of tissue regeneration and biocompatibility (Anjum et al., 
2016). Importantly, infected wounds require high local concentrations 
of antimicrobials over prolonged periods, therefore, formulations 
increasing the antimicrobial and anti-inflammatory effects while 
reducing chances for resistance development are preferred (Lam et al., 
2018). Liposomes-in-hydrogel for antimicrobials is a promising strategy 
in treatment of infected wounds. The synergy between formulations and 
antimicrobials create a potential therapeutic advantage. 
3.1. Characteristics of CHX-liposomes and liposomes 
Liposomes are extensively used in studies targeting skin therapies. 
These lipid-based vesicles provide sustained and controlled release of 
associated antimicrobial compounds from a safe carrier (Filipczak, Pan, 
Yalamarty, & Torchilin, 2020; Gonzalez Gomez & Hosseinidoust, 2020; 
Ibaraki et al., 2020). They provide a reservoir for compounds within the 
skin layers increasing the local concentration (Lai et al., 2020; Peers 
et al., 2020). The optimal size considering a depot effect should be 
around 200− 300 nm (Ternullo, Schulte Werning et al., 2019). Gener-
ally, the size of liposomes is very likely influencing the antibacterial 
activity (Martin et al., 2015). Indeed, it has been reported that con-
ventional liposomes that were effective in delivery of antimicrobials to 
biofilms had a size significantly below 500 nm (Rukavina & Vanić, 
2016). For example, amikacin-loaded liposomes with a mean diameter 
of approximately 300 nm penetrated readily into P. aeruginosa biofilm 
and infected mucus (Meers et al., 2008). Similarly, azithromycin-loaded 
liposomes of about 400 nm were able to reduce the growth of 
P. aeruginosa in biofilm (Solleti, Alhariri, Halwani, & Omri, 2015). 
However, the liposomes in our study were incorporated in hydrogels and 
not applied as suspensions; therefore, the effect of their size should be 
rather limited. We generated liposomes of a homogenous size distribu-
tion exhibiting a relatively low polydispersity index (PI, Table 1). The 
size of CHX-liposomes was confirmed with transmission electron mi-
croscopy (TEM, Fig. S1). Moreover, the images showed spherical lipo-
somes with well-defined surfaces. The liposomes, in addition to all other 
formulations presented in this study, are summarized in Table S1. 
The zeta potential of empty liposomes was neutral due to the high 
content of neutral phosphatidylcholine (>94 %), however, CHX- 
liposomes exhibited zeta potential of almost 50 mV (Table 1), making 
them highly cationic due to presence of CHX. The physiochemical nature 
of CHX and its biguanide groups would point to CHX being incorporated 
within and onto the bilayer of liposomes, which could further increase 
potential interactions with bacterial membranes (Farkas, Zelkó, Török, 
Rácz, & Marton, 2001). Recently, Ibaraki and colleagues reported 
increased damage to bacterial biofilms by cationic compared to anionic 
liposomes (Ibaraki et al., 2020). The amphipathic nature of CHX allows 
its distribution stretched towards the core in the inner layer and the 
surface and within the bilayer resulting in a considerably high entrap-
ment (Hassan et al., 2013). 
We evaluated the stability of liposomal dispersions over 4 weeks and 
did not detected any significant changes in their characteristics (data not 
included). 
3.2. Characteristics of hydrogel 
Liposomes require secondary vehicles such as hydrogels to remain on 
the skin. A key feature of hydrogels in skin therapy is to offer mechanical 
stability. Hydrogel′s texture properties are often measured as an indi-
cator of mechanical stability. Texture analyses provide both in-process 
controls and information on stability (Hurler et al., 2012a). The rele-
vant parameters are hardness, cohesiveness and adhesiveness. The 
hardness describes the skin applicability of the formulation (Ternullo, 
Schulte Werning et al., 2019). The cohesiveness defines the recovery of 
the structural network within hydrogel after application and level of 
deformation (Amasya, Inal, & Sengel-Turk, 2020). The adhesiveness 
represents the ability to remain on the skin (Hurler et al., 2012a). These 
features define the applicability and user-friendliness of hydrogels. 
The texture properties are influenced by plasticisers and polymer 
concentrations and the addition of glycerol increased the hydrogel 
hardness (Fig. 1). This was evident from the results of the glycerol-free 
hydrogel and the CHX-liposomes-in-glycerol-free hydrogel. CHX, in 
liposomes-in-hydrogel or free in the hydrogel, did not affect the 
hydrogel hardness. The cohesiveness did not follow the same pattern as 
the hardness; all hydrogels demonstrated similar cohesiveness, except 
from the glycerol-free hydrogel (4.5 %, Fig. 1) that exhibited a signifi-
cantly higher cohesiveness compared to other formulations. Glycerol 
was added to hydrogels to improve the long-term texture properties 
(Hurler et al., 2012a) as well as the level of deformation within the 
hydrogel, the cohesiveness. Glycerol could create three hydrogen bonds 
with the amino sugar unit and subsequently increase the mobility (Chen 
et al., 2018). The adhesiveness decreased when CHX-liposomes were 
incorporated into the hydrogel as compared to liposome. 
Our results cannot be directly compared to other studies since we 
applied higher polymer concentrations and modified set-up. For 
example, Ternullo and colleagues observed reduced texture properties 
upon addition of liposomes, whereas Jøraholmen and colleagues 
observed the opposite (Jøraholmen et al., 2019; Ternullo, Schulte 
Werning et al., 2019). 
The pH of hydrogels was also investigated (Table S3) to assure an 
appropriate pH of the final formulation. Although the CHX-liposomes 
demonstrated a higher pH, liposomes were merely the primary formu-
lation since the CHX-liposomes were further incorporated within a 
chitosan hydrogel network. The pH of the hydrogels was significantly 
lower than the pH of the CHX-liposomes, assuring that externally 
applied formulation does not elevate the issue of high pH; on the con-
trary, it acts on lowering pH. 
Table 1 
Characteristics of liposomes and CHX-liposomes.  
Sample Size (nm) PIa Zeta (mV) pH EE (%)b 
Liposomes 271 ± 16 0.33 ± 0.07 − 0.4 ± 0.3 6.9 ± 0.2 – 
CHX-liposomes 318 ± 9* 0.24 ± 0.03* 45.5 ± 1.3* 8.0 ± 0.1 94.7 ± 0.7 
Results are expressed as means with their respective SD (n = 3, * n = 6). 
a Polydispersity index. 
b Entrapment efficiency (%). 
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3.3. Stability of chitosan hydrogels 
The stability testing expressed as the changes of the hydrogels′
texture properties (Table S2) indicates that the cohesiveness and adhe-
siveness of hydrogels comprising glycerol and liposomes remained more 
stable over a period of 4 weeks than plain hydrogel of the same con-
centration, probably due to stabilizing effect of both glycerol and lipo-
somes. Additionally, the CHX-liposomes-in-hydrogel exhibited 
satisfying stability for the evaluation period. This stability could be 
attributed to the charge of both CHX-liposomes and chitosan, creating 
repulsive effects through electrostatic forces (Ternullo, Schulte Werning 
et al., 2019). The liposomal bilayer is electrostatically stabilized and the 
repulsions might decelerate the release of CHX into the hydrogel 
network (Grijalvo et al., 2020). The basic CHX is only slowly released 
into the network, and this would possibly lead to a stable pH in the 
network. Since liposomes most likely preserve their original size without 
aggregation, the network mobility would be more stable. In addition, 
Hurler and colleagues studied the effects of zeta potential of liposomes 
on the properties of the liposomes-in-hydrogel formulations. The au-
thors postulated that liposomes bearing a positive charge seem to sta-
bilize the chitosan hydrogel network better than neutral or negatively 
charged liposomes (Hurler et al., 2013). The pH of hydrogels (Table S3) 
remained stable over four weeks. However, liposomes-in-hydrogels, 
both with and without CHX, exhibited a small increase in pH. 
3.4. Release of CHX 
Considering skin therapy, liposomes-in-hydrogel should provide 
sustained CHX release assuring bacterial eradication without regrowth, 
reduced administration frequency and improved patient compliance 
(Smith et al., 2020). Additionally, antimicrobial-liposomes-in-hydrogel 
formulations prevent burst release from polymeric networks or lipo-
somes alone (Grijalvo et al., 2020). 
In Fig. 2, the CHX release (24 h) is presented. CHX-liposomes 
exhibited sustained release compared to the permeating free CHX (p 
<0.1). However, incorporation of CHX-liposomes into chitosan hydrogel 
significantly sustained the release (p < 0.05). No differences in release 
between liposomes-in-hydrogels with and without glycerol were 
observed. Chitosan hydrogels without liposomes failed to reduce CHX 
release indicating that liposomes were crucial to provide a sustained 
release of CHX. Similarly, CHX release from montmorillonite and chi-
tosan composite was reported to be controlled and sustained as 
compared to free CHX (Onnainty et al., 2016). 
These results emphasize the importance of including both systems, 
liposomes and hydrogel, in the final formulation. In addition to the 24 h 
endpoint release, we performed preliminary studies on the release 
profile from CHX-liposomes, CHX-liposomes-in-hydrogel, CHX- 
liposomes-in-glycerol-free hydrogel and free CHX (Fig. S2). The same 
patterns as observed in the 24 h endpoint measurements (Fig. 2) were 
confirmed in hourly release profile; however, we noticed the fluid ex-
change between the donor and acceptor chamber. Therefore, we pro-
ceeded with the endpoint measurement of the release. 
3.5. Bioadhesive properties 
The efficacy of formulations destined for skin administration is 
influenced by their bioadhesive properties. Hurler and colleagues 
developed a method to determine the amount of hydrogel that remained 
on the skin after compression rather than measuring force of detachment 
(Hurler & Škalko-Basnet, 2012). The bioadhesive properties of tested 
hydrogels are found in Fig. 3. All hydrogels were bioadhesive; however, 
liposomes-in-hydrogel displayed the highest bioadhesive properties. 
Most often, reports on bioadhesion refer to mucosal adhesion; 
however, mechanisms for skin adhesion are also reported (Horstmann, 
Müller, & Asmussen, 1999; Venkatraman & Gale, 1998). The adhesion 
to skin is, unlike to the mucosa, more dependent on the surface structure 
Fig. 1. The texture properties of chitosan hydrogels measured as hardness, cohesiveness and adhesiveness. The values are expressed as mean of three replicates with 
their respective SD. 
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and size of the surface area (Horstmann et al., 1999). Moreover, the 
bioadhesion could potentially be affected by interpenetration between 
the polymer and biological surface (Palacio & Bhushan, 2012), more-
over the plasticizer could increase bioadhesion (Horstmann et al., 1999). 
3.6. Anti-inflammatory evaluation 
Macrophages play an important role in skin infections and in-
flammations by regulating the production of NO (Kloc et al., 2019). The 
reduced NO level has been considered beneficial after the inflammatory 
phase of wound healing. We evaluated the anti-inflammatory effects of 
chitosan formulations and CHX; CHX is expected to have a mild effect on 
inflammation in this experimental set-up by neutralizing LPS through 
binding (Zorko & Jerala, 2008). 
Our results confirmed a dose-dependent reduction in NO production 
(Fig. 4). Even though the difference in production between 1 and 10 μg 
mL− 1 was not statistically different except for the CHX-liposomes-in- 
hydrogel, a clear tendency could be observed. All formulations 
demonstrated a significant reduction in NO production between 10 and 
50 μg mL− 1. Furthermore, all formulations at every concentration, 
except liposomes (1 μg mL− 1), demonstrated a significant reduction in 
NO production compared with the control (non-treated LPS-induced 
macrophages). The reduction of NO production in the cells treated 
with hydrogels either with or without CHX liposomes demonstrated a 
significantly reduced NO production. 
Chitosan-based formulations have previously been reported to 
reduce inflammatory response in macrophages; however, the results 
were often dependent on MW of chitosan (Chang, Lin, Wu, Huang, & 
Tsai, 2019). Our group has reported anti-inflammatory activity of 
liposomes-in-hydrogel formulation with polyphenols (Jøraholmen et al., 
Fig. 2. CHX release or permeation over 24 h at 32 ◦C. Results are represented as percentage of CHX released compared to the initial concentration. Results are 
expressed as mean of three replicates with their respective SD. 
Fig. 3. Bioadhesive properties of chitosan hydrogels and liposomes-in-hydrogel. The bioadhesion is presented as the amount of hydrogel retained on the skin (%) 
after compression compared to the original amount applied to the die in the rig set to the Texture Analyser. The results are presented as the mean of three replicates 
with their respective SD. 
*) Significantly different (p < 0.05). 
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2019). In their study, the anti-inflammatory response was lower than we 
observed, however, the chitosan concentration used in this study was 
significantly lower than in our study. Since we used higher chitosan 
concentrations, the differences may indicate that chitosan concentration 
plays a role in modulating anti-inflammatory response. However, we 
measured nitrites as an indicator for NO. Due to the anionic nature of 
nitrites, chitosan might neutralize these inorganic anions (Il’ina & 
Varlamov, 2016) leading to lower concentration of available nitrites for 
the Griess reaction. Consequently, the values may be an overestimation 
of the anti-inflammatory effect and should be further investigated. The 
most important characteristic to verify is that new formulations for 
wound therapy do not induce an additional inflammation response, 
which would lead to impaired healing. Pettinelli and colleagues 
demonstrated that chitosan hydrogel did not induce any inflammation 
response in macrophages (Pettinelli et al., 2019). In addition to the 
evaluation of NO production in macrophages, we evaluated the cell 
viability of immortalized human keratinocytes treated with 
CHX-liposomes (Fig. S3). The results demonstrated improved viability of 
cells treated with CHX-liposomes. 
3.7. Antimicrobial evaluation 
3.7.1. Minimal lethal concentration (MLC) of formulated and free CHX 
The treatment of wound infections is challenging due to the growing 
problem of antibiotic resistance and tendency of S. aureus and 
P. aeruginosa to form biofilms (Serra et al., 2015). Chitosan demonstrates 
antimicrobial properties towards gram-positive bacteria (Hamedi, 
Moradi, Hudson, & Tonelli, 2018; Moeini et al., 2020). Since infected 
wounds comprise polymicrobial manifestation, we aimed to take 
advantage of the synergic effects of chitosan and CHX to ameliorate the 
available antibacterial therapies against both bacteria. 
We investigated the MLC of free CHX and formulated CHX (lipo-
somes and hydrogels with glycerol) for three bacterial strains (Table S4). 
As expected, free CHX exerted strong antimicrobial activity against both 
S. aureus and P. aeruginosa. The effects were retained in CHX- liposomes, 
whilst empty liposomes were inactive. Importantly, the incorporation of 
CHX-liposomes in chitosan hydrogel improved the CHX antibacterial 
effect, as demonstrated by the lowering of MLC for all tested strains. In 
addition, hydrogel (4.5 %) revealed an antibacterial activity itself, since 
it inhibited S. aureus ATCC29213, S. aureus SO88 and P. aeruginosa 
ATCC10145 at dilutions corresponding to chitosan concentrations of 
0.056 %, 1.125 % and 2.25 %, respectively. 
3.7.2. Inhibitory activity against planktonic cultures 
Considering topical application for the treatment of wounds, the 
antimicrobial activities towards planktonic culture were evaluated in 
SWF. The viability of S. aureus and P. aeruginosa in SWF was compared in 
the presence of free or formulated CHX (Fig. 5). The untreated bacteria 
and bacteria exposed to liposomes retained viability. In presence of free 
CHX, no viable cells were found after 3 h. 
CHX-liposomes and CHX-hydrogels both retained antimicrobial ac-
tivity against planktonic cultures but with delayed effects, due to sus-
tained release of CHX. In particular, CHX-hydrogel completely abolished 
viability after 9 h, while CHX-liposomes and CHX-liposomes-in- 
hydrogel required 24 h to achieve a complete depletion of bacterial 
cells. Interestingly, after 6 and 8 h the antimicrobial effects against all 
tested microorganisms were more marked for CHX-liposomes-in- 
hydrogels than for CHX-liposomes (p < 0.05), even if release studies 
showed a reduced release of CHX from CHX-liposomes-in-hydrogels. 
However, in all cases no viable bacteria were found after 24 h of incu-
bation with formulated CHX (liposomes or hydrogels), as well as with 
free CHX. It is worth noting that hydrogel without CHX reduced S. aureus 
viability by 1.27–1.55 log CFU after 24 h, while cell viability of 
P. aeruginosa decreased by 1.14 log CFU. This is in agreement with MLC 
data and suggests that chitosan-based wound treatment improves the 
antimicrobial potential of CHX. 
3.7.3. Anti-biofilm activity 
Considering that S. aureus and P. aeruginosa biofilms are often asso-
ciated with chronic infections and decreased susceptibility to antimi-
crobial treatments (Roy, Tiwari, Donelli, & Tiwari, 2018), we focused on 
anti-biofilm activity of free and formulated CHX against S. aureus 
ATCC29213, S. aureus SO88 and P. aeruginosa ATCC10145 by means of 
dispersal and biofilm formation inhibition assays (Fig. 6). Free CHX 
revealed a moderate anti-biofilm activity, reducing the biofilm forma-
tion of all tested microorganisms (inhibition of 42–51 %) and partially 
eradicating pre-formed biofilm (eradication rate of 29–43 %). 
Contrary to what was observed for planktonic cultures, the 
Fig. 4. Anti-inflammatory evaluation on mu-
rine macrophages (RAW 264.7). Concentrations 
refer to the lipid concentration or correspond-
ing concentration where lipids are not present. 
The NO production is presented as the per-
centage compared to the NO production in non- 
treated LPS-induced macrophages (100 %). All 
results are expressed asmeans of three parallels 
with their respective SD. 
*) Significantly different compared to non- 
treated LPS-induced macrophages (p < 0.05).   
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incorporation of CHX inside liposomes significantly enhanced its ability 
both to counteract biofilm formation (inhibition of 53–63 %) and to 
disperse pre-formed biofilm (eradication rate of 40–53 %, p < 0.05). The 
increased anti-biofilm activity of CHX-liposomes might be due to a more 
efficient penetration of positively charged liposomes into the extracel-
lular matrix of biofilms (Rukavina & Vanić, 2016). Our finding is in 
agreement with data on incorporation of vancomycin (Scriboni et al., 
2019) and gentamicin (Alhariri et al., 2017) in liposomes, which 
improved the penetration of S. aureus and P. aeruginosa biofilms, 
respectively. Moreover, reports show that cationic formulations could 
potentially extend the penetration of active compounds into bacterial 
biofilm, which are probably negatively charged (Drulis-Kawa et al., 
2009; Robinson, Bannister, Creeth, & Jones, 2001). Nevertheless, the 
composition of external matrix of biofilm is very complex and hetero-
geneous and can be influenced by numerous factors including surface 
properties, nutrient availability and microbial species that form the 
biofilm (Flemming & Wingender, 2010). Thus, we can only make as-
sumptions. However, different authors reported that cationic vesicles 
showed better performances compared to free active compounds or 
negatively charged vesicles in targeting biofilm of Staphylococcus spp., 
including S. aureus (Rukavina & Vanić, 2016). Actually, our results 
support the hypothesis that liposomes and cationic formulations may 
improve the delivery of active compounds to biofilms. 
As expected, liposomes showed no anti-biofilm activity, while 
hydrogels without CHX exhibited a mild anti-biofilm effect (p < 0.05). 
Consequently, CHX-hydrogel improved activity as compared to free 
CHX (p < 0.05). 
Notably, the best anti-biofilm profile was observed for CHX- 
liposomes-in-hydrogels, and was significantly better than CHX- 
liposomes. In particular, CHX-liposomes-in-hydrogels almost 
completely inhibited the formation of S. aureus and P. aeruginosa biofilm, 
while the eradication rate was higher for S. aureus (82–98 %) than for 
P. aeruginosa (64 %). These results suggest that the insertion of CHX- 
liposomes inside chitosan hydrogel is a promising and innovative 
strategy to treat wound infections. 
4. Conclusion 
To address the challenges related to both treatment of chronic 
wounds comprising biofilms and increased antimicrobial resistance, we 
developed novel antimicrobial chitosan-based system. The system 
comprising liposomally-associated CHX in chitosan hydrogel exhibited 
superior anti-biofilm activities while maintaining properties relevant for 
skin administration. In addition, we observed anti-inflammatory effects 
of the chitosan hydrogel, an important feature considering wound 
therapy. 
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(2013). The effect of lipid composition and liposome size on the release properties of 
liposomes-in-hydrogel. International Journal of Pharmaceutics, 456(1), 49–57. 
Ibaraki, H., Kanazawa, T., Chien, W.-Y., Nakaminami, H., Aoki, M., Ozawa, K., & Seta, Y. 
(2020). The effects of surface properties of liposomes on their activity against 
Pseudomonas aeruginosa PAO-1 biofilm. Journal of Drug Delivery Science and 
Technology, 57, Article 101754. 
Fig. 6. Anti-biofilm activity: inhibition of biofilm development (%) on left Y- 
axis (petrol bars), eradication of pre-formed biofilm (%) on the right Y-axis 
(orange bars). The results are presented as the mean of three replicates with 
their respective SD. 
*) Significantly different from untreated control (p < 0.05). 
a: S. aureus ATCC29213; b: S. aureus SO88; c: P. aeruginosa ATCC10145. 
L.M. Hemmingsen et al.                                                                                                                                                                                                                       
Carbohydrate Polymers 262 (2021) 117939
10
Il’ina, A. V., & Varlamov, V. P. (2016). Neutralization of reactive oxygen species by 
chitosan and its derivatives in vitro/in vivo (Review) Applied Biochemistry and 
Microbiology, 52(1), 1–14. 
Islam, M. M., Shahruzzaman, M., Biswas, S., Nurus Sakib, M., & Rashid, T. U. (2020). 
Chitosan based bioactive materials in tissue engineering applications-A review. 
Bioactive Materials, 5(1), 164–183. 
Jøraholmen, M. W., Basnet, P., Tostrup, M. J., Moueffaq, S., & Škalko-Basnet, N. (2019). 
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